| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w19522 |
| 来源ID | Working Paper 19522 |
| Pharmaceutical Followers | |
| Peter Arcidiacono; Paul B. Ellickson; Peter Landry; David B. Ridley | |
| 发表日期 | 2013-10-10 |
| 出版年 | 2013 |
| 语种 | 英语 |
| 摘要 | We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and ``me-too'' drugs each increased consumer welfare more than $100 million in 2010, holding insurance premiums constant. However, insurance payments in 2010 fell by nearly $1 billion due to generics and rose by over $7 billion due to me-too antiulcer drugs. |
| 主题 | Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance ; Industry Studies |
| URL | https://www.nber.org/papers/w19522 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/577195 |
| 推荐引用方式 GB/T 7714 | Peter Arcidiacono,Paul B. Ellickson,Peter Landry,et al. Pharmaceutical Followers. 2013. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
